Insiders · Profile

GANNON STEVEN

Director at Xenon Pharmaceuticals. Filing since 11 Aug 2017. CIK 0001643085

Company

Date

Role

Action

Shares

Amount

Of holding

XENE Xenon Pharmaceuticals Inc.

11 Aug 2026

Director

Sold at will

10,000

$640.55K

84.2%

XENE Xenon Pharmaceuticals Inc.

5 Jun 2025

Director

Sold at will

3

$91.44

0.0%

XENE Xenon Pharmaceuticals Inc.

7 Mar 2024

Director

Sold at will

13,000

$601.61K

86.7%

XENE Xenon Pharmaceuticals Inc.

11 Aug 2017

Director

Bought

15,000

$42.27K

opened

4 decisions on file.